Home About Product Development Clinical Trials Technology Licensing Opportunities Contact

CMX001 Clinical Trial Info

Phase I clinical development for smallpox and CMV

A blinded, randomized, parallel-group, placebo-controlled Phase I clinical study to evaluate the safety and pharmacokinetics of orally administered CMX001 in healthy volunteers is in progress.

Latest News

May 19, 2008

Researchers Find Smallpox Drug May Also Target Adenovirus

[more]

April 3, 2008

Potential wonder drugs - Chimerix article in The New Economy

[more]

read all news

Next Event

April 18, 2008 - Chimerix to present at 25th Annual Venture Conference

Chimerix company overview

[more]

June 10, 2008 - Chimerix to present at XVII International HIV Drug Resistance

Hexadecyloxypropyl tenofovir (CMX157) Has Enhanced Potency in Vitro against NRTI Resistant HIV Relative to Tenofovir and a Favorable Preclinical Profile

[more]